Novavax, Inc. (NVAX) Reports Q3 Loss of $0.03
Tweet Send to a FriendGet Alerts NVAX Hot Sheet
Price: $2.02 -0.98%
Revenue Growth %: -18.1%
Financial Fact:
Basic and diluted net loss per share: -0.07
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: -18.1%
Financial Fact:
Basic and diluted net loss per share: -0.07
Today's EPS Names:
ANF, DXLG, FL, More
Trade NVAX Now!
Novavax, Inc. (NASDAQ: NVAX) reported Q3 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.37 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
- Mentor Graphics Corp (MENT) Tops Q1 EPS by 5c; Guides Q2, FY14
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
